Brief: BioInvent Q3 Sales SEK 12.8 Million

BioInvent International AB

31/10/2024 07:00

Oct 31 (Reuters) - BioInvent Q3 adjusted free cash flow SEK -97 million.
* Q3 net income SEK -97.2 million
* Q3 adjusted EPS SEK -1.48